+ Direct Access
July 11, 2016

icTV update with Claude Guerin

APRONET is a ONE-day prevalence study initiated by the ESICM Acute Respiratory Failure Section, which aims to answer this question. Principal Investigator Claude Guerin discusses this multicentre observational prospective study, which is still registering centres for one of the three upcoming dates. 

To learn more about APRONET and to register your ICU in this exciting study from the ESICM Trials Group, visit here.

Comment on this news